Application of CCK-8 as RIPK1 inhibitor

The invention discloses an application of CCK-8 as an RIPK1 inhibitor. Belongs to the technical field of medicines. CCK-8 can inhibit necroptosis of cells; the CCK-8 can be used for effectively inhibiting the activity of the RIPK1; the CCK-8 can be used as an RIPK1 inhibitor for treating necrotic apoptosis, acute brain, lung, kidney and heart injuries, various organ inflammations, multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, psoriasis, systemic inflammatory response syndrome induced by tumor necrosis factors, inflammatory bowel disease, amyotrophic lateral sclerosis and frontotemporal dementia. The invention provides a novel solution for the treatment of such diseases as acute ischemic injury, cerebral acute or ischemic injury, acute or ischemic injury, systemic lupus erythematosus, sepsis, rheumatoid arthritis, sore, carbuncle and ulceration, heat stroke, burn infection and the like, and provides a novel solution for the treatment of such diseases as acute isch